Fig. 2: Reasons for permanent treatment discontinuation over time in patients with Ph+ CP CML.

Patients grouped by (A) age and (B) comorbidities. CML chronic myeloid leukemia, CP chronic phase, mCCI Charlson Comorbidity Index without age component, Ph Philadelphia chromosome.